MNTL Industry Affiliates Program
ElectroCyt, a start-up company founded by Bioengineering Professor Rashid Bashir and alumnus Bobby Reddy( PhD 2012) and based on their novel microfluidic and electrical sensing technology, received stage 1 funding from the VentureWell student grant program in 2016. The ElectroCyt team has created a diagnostic tool that will improve accuracy when diagnosing sepsis, a lifethreatening condition that occurs when harmful bacteria and toxins enter the bloodstream and trigger inflammatory response throughout the body. ElectroCyt’ s first-degree sensing technology can detect and prevent a number of diseases and conditions well before debilitating symptoms present themselves. The company also developed the world’ s first handheld Complete Blood Count( CBC) diagnostic platform.
ElectroCyt’ s differential immune-capture biochip takes whole blood as input, eliminating the need of off-chip sample preparation and effectively reducing the assay time.
ElectroCyt’ s first-degree sensing technology can detect and prevent a number of diseases and conditions well before debilitating symptoms present themselves.
MNTL Industry Affiliates Program
In 2016, MNTL launched a new Industry Affiliates Program to facilitate technical interactions between company researchers and Illinois faculty and students. With membership rates based on company size and level of interest, the IAP enables companies to partner with faculty on pre-competitive research projects, providing a cost-effective approach for gaining insight into commercial applications of university research. The IAP is also developing an MNTL graduate student industry recruiting pipeline, connecting uniquely qualified students with company internships and full-time employment.
micro + nanotechnology lab | 15 | 2016 highlights report